Associate Director, Gene Editing, Technology Development @ (January 2023 - August 2024)
Principal Scientist-Gene Editing Technologies @ (March 2022 - January 2023)
Principal Investigator, CEO, Co-Founder @ Verge Therapeutics, Inc (October 2018 - March 2023)
Director of Research and Development @ CurlBio, LLC (May 2015 - September 2018)
Director, Cell Biology @ (June 2014 - January 2016)
Director of Biology @ (July 2010 - May 2015)
Research Assistant Professor @ (September 2009 - July 2010)
Sarah Compton Education
Medical College of Virginia
Doctor of Philosophy - PhD (Pharmacology and Toxicology)
Sarah Compton Skills
Assay Development
Biotechnology
CRISPR therapeutics
Cell
Cell Biology
Cell Culture
Cross-functional Team Leadership
Drug Discovery
External Partnerships
Flow Cytometry
Genetic Medicines
High Throughput Screening
IND-enabling Research
In Vitro
Planning Budgeting & Forecasting
RNA therapeutics
Resource Management
Scientific Leadership
Team Development
Tissue Culture
Translational Research
Development
Research
Sarah Compton Summary
Sarah Compton, based in Chapel Hill, NC, US, is currently a Director, Translational Biology, Genomic Medicines at ElevateBio. Sarah Compton brings experience from previous roles at ElevateBio, Verge Therapeutics, Inc and CurlBio, LLC. Sarah Compton holds a Doctor of Philosophy - PhD in Pharmacology and Toxicology @ Medical College of Virginia. With a robust skill set that includes Assay Development, Biotechnology, CRISPR therapeutics, Cell, Cell Biology and more. Sarah Compton has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Sarah Compton?
Find contact details for 700 million professionals.